BASILEA PHARMACEUTICALS A/S: Financial statements 2012
CVR: 30723732
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BASILEA PHARMACEUTICALS A/S (CVR 30723732) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 3,864,842 and a net result of DKK 919,943. Equity in the 2012 report amounted to DKK 4,502,770. The solvency ratio was 96.3%.
- Gross Profit
- DKK 3,864,842
- Profit/Loss
- DKK 919,943
- Equity
- DKK 4,502,770
- Total Assets
- DKK 4,677,747
Official annual report
Keep an eye on BASILEA PHARMACEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of August 30, 2012, Elizabeth Rozek has joined the board of directors of BASILEA PHARMACEUTICALS A/S.
As of August 30, 2012, Joachim Emil Blatter has left the board of directors of BASILEA PHARMACEUTICALS A/S.
As of July 20, 2012, Joachim Emil Blatter has joined the board of directors of BASILEA PHARMACEUTICALS A/S.
As of July 20, 2012, Daniel Feuz has joined the board of directors of BASILEA PHARMACEUTICALS A/S.
As of July 20, 2012, Kim Arvid Nielsen has left the board of directors of BASILEA PHARMACEUTICALS A/S.
As of July 20, 2012, Ole Nygaard Pedersen has left the board of directors of BASILEA PHARMACEUTICALS A/S.
As of July 20, 2012, Joachim Emil Blatter is registered as direktion of BASILEA PHARMACEUTICALS A/S.
As of July 20, 2012, Kim Arvid Nielsen has stepped down as direktion of BASILEA PHARMACEUTICALS A/S.
About BASILEA PHARMACEUTICALS A/S
BASILEA PHARMACEUTICALS A/S was a Danish company of the type Aktieselskab based in København V, founded in 2007. The company has been dissolved on 19 September 2017. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2012). In 2016, the company reported a gross profit of DKK -35,500 and a net result of DKK 15,967 compared with DKK -30,567 the year before. Equity in the 2016 report amounted to DKK 4,200,146.